Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab

Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab

Saved in:
Bibliographic Details
Published in:Scientific reports Vol. 13; no. 1; p. 11935
Main Authors: Matsumoto, Toshihiko, Ikoma, Tatsuki, Yamamura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Nagai, Hiroki, Takatani, Masahiro, Yasui, Hisateru
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 24-07-2023
Nature Publishing Group
Nature Portfolio
Subjects:
Author
Author Correction
Colorectal carcinoma
Humanities and Social Sciences
multidisciplinary
Science
Science (multidisciplinary)
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-023-39009-5